Interim results of Intergroup EC-Doc Trial: A randomized multicenter phase III trial comparing adjuvant CEF/CMF to EC-docetaxel in patients with 1-3 positive lymph nodes

被引：3

作者：

Nitz, U.

Huober, J. B.

Lisboa, B.

Harbeck, N.

Fischer, H.

Moebus, V.

Hoffmann, G.

Augustin, D.

Weiss, E.

Kuhn, W.

机构：

[1] W German Study Grp, Monchengladbach, Germany

[2] Univ Hosp, Tubingen, Germany

[3] Univ Hosp, Hamburg, Germany

[4] Univ Hosp, Munich, Germany

[5] Protestant Hosp, Oberhausen, Germany

[6] City Hosp Hoechst, Frankfurt, Germany

[7] St Josef Hosp, Wiesbaden, Germany

[8] City Hosp, Deggendorf, Germany

[9] City Hosp, Boblingen, Germany

[10] Univ Hosp, Bonn, Germany

来源：

关键词：

D O I：

10.1200/jco.2008.26.15_suppl.515

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

515

引用

页数：1